Sep 22, 2026 10 0
Uploaded by Logic
Favorite
Share
More Options
7
Case Report: Multimodal Immunotherapeutic Regimen (Envafolimab + Chemotherapy + Radiotherapy) for Four Synchronous Primary Malignant Neoplasms - A Case Report of 33-Month Survival and Implications for Tumor Immunology_Page 1

Open in WPS to view all 7 pages